MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN AND ADOLESCENTS TEMPORARILY ASSOCIATED WITH COVID-19: CLINICAL AND LABORATORY FEATURES
https://doi.org/10.24412/2790-1289-2022-1-7075
Abstract
Сoronavirus infection (COVID-19) is a new, changing disease; several strains of COVID-19 mutated virus have already been reported. In children there have been described cases of acute disease with signs of Kawasaki disease and toxic shock syndrome, hyperreactive inflammation leading to multiple organ failure and shock [3; 4; 5]. This variant of the clinical course is referred to as multisystem inflammatory syndrome (MIS) in children and adolescents, temporarily associated with COVID-19. We analyzed the case histories of 14 children hospitalized at Children's Clinical Hospital №2 Almaty with the substantiation of a diagnosis of MIS temporarily associated with COVID-19. Clinical and laboratory features of this condition in children were determined. The average age was 5.5 years. By severity of condition, half of the children (50%) were admitted to intensive care unit. The examined children had symptoms corresponding to WHO criteria of MIS diagnosis - rash, abdominal syndrome (abdominal pain), diarrhea, vomiting. All patients had a significant increase in D-dimer from 430 to 6960 ng/ml.
About the Authors
K. K. OrynbasarovaKazakhstan
MD, Ass. Professor
S. K. Saparbekov
Kazakhstan
master of medicine
N. O. Asanova
Kazakhstan
U. A. Uskenbaeva
Kazakhstan
References
1. Liguoro I., Pilotto C., Bonanni M., Ferrari M.E., Pusiol A., Nocerino A., et al. SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179 (7):1029-1046.
2. Salvatore C.M., Han J-Y., Acker K.P., Tiwari P., Jin J., Brandler M., et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health. 2020; 4 (10): 721-727.
3. Pod red. D.Ju. Ovsjannikova, E.E. Petrjajkinoj. Detskij mul'tisistemnyj vospalitel'nyj sindrom, associirovannyj s novoj koronavirusnoj infekciej (COVID-19): uchebnoe posobie. M.: Rossijskij Universitet Druzhby Narodov; 2020. - 81 s. (in Russian)
4. Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395 (10237): P1607-1608.
5. Kaushik A., Gupta S., Sood M., Sharma S., Verma S. A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection. Pediatr Infect Dis J. 2020; 39 (11): R340-346.
6. www.WHO.int/publications/item/multisysteminflammatorysyndromeinchildrenandadolescentswithCovid-19/WorldHealthOrganization/ScientifBrief. (electronicresource)
7. Koronavirusnaja infekcija COVID-19 u detej. / Klinicheskij protokol diagnostiki i lechenija ot «16» oktjabrja 2020 goda Protokol №117. - RCRZ Ministerstva zdravoohranenija Respubliki Kazahstan. (in Russian)
8. Rol' immunohimicheskih jekspress-testov dlja opredelenija antigenov v diagnostike infekcii, vyzvannoj virusom SARS-CoV-2: Vremennye rekomendacii VOZ; Zheneva: Vsemirnaja organizacija zdravoohranenija; 2020 g. (in Russian).
Review
For citations:
Orynbasarova K.K., Saparbekov S.K., Asanova N.O., Uskenbaeva U.A. MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN AND ADOLESCENTS TEMPORARILY ASSOCIATED WITH COVID-19: CLINICAL AND LABORATORY FEATURES. Actual Problems of Theoretical and Clinical Medicine. 2022;(1):70-75. (In Russ.) https://doi.org/10.24412/2790-1289-2022-1-7075